172 related articles for article (PubMed ID: 37544422)
1. A novel Toll-like receptor 7/8-specific antagonist E6742 ameliorates clinically relevant disease parameters in murine models of lupus.
Ishizaka ST; Hawkins L; Chen Q; Tago F; Yagi T; Sakaniwa K; Zhang Z; Shimizu T; Shirato M
Eur J Pharmacol; 2023 Oct; 957():175962. PubMed ID: 37544422
[TBL] [Abstract][Full Text] [Related]
2. Discovery of M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor for Treatment of Autoimmunity.
Vlach J; Bender AT; Przetak M; Pereira A; Deshpande A; Johnson TL; Reissig S; Tzvetkov E; Musil D; Morse NT; Haselmayer P; Zimmerli SC; Okitsu SL; Walsky RL; Sherer B
J Pharmacol Exp Ther; 2021 Mar; 376(3):397-409. PubMed ID: 33328334
[TBL] [Abstract][Full Text] [Related]
3. Human and Murine Toll-like Receptor-Driven Disease in Systemic Lupus Erythematosus.
von Hofsten S; Fenton KA; Pedersen HL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791389
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 8 deletion accelerates autoimmunity in a mouse model of lupus through a Toll-like receptor 7-dependent mechanism.
Tran NL; Manzin-Lorenzi C; Santiago-Raber ML
Immunology; 2015 May; 145(1):60-70. PubMed ID: 25424423
[TBL] [Abstract][Full Text] [Related]
5. TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice.
Desnues B; Macedo AB; Roussel-Queval A; Bonnardel J; Henri S; Demaria O; Alexopoulou L
Proc Natl Acad Sci U S A; 2014 Jan; 111(4):1497-502. PubMed ID: 24474776
[TBL] [Abstract][Full Text] [Related]
6. First-in-Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E6742, a Dual Antagonist of Toll-like Receptors 7 and 8, in Healthy Volunteers.
Yamakawa N; Tago F; Nakai K; Kitahara Y; Ikari S; Hojo S; Hall N; Aluri J; Hussein Z; Gevorkyan H; Maruyama T; Ishizaka S; Yagi T
Clin Pharmacol Drug Dev; 2023 Apr; 12(4):363-375. PubMed ID: 36219471
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent, orally bioavailable in vivo efficacious antagonists of the TLR7/8 pathway.
Alper PB; Deane J; Betschart C; Buffet D; Collignon Zipfel G; Gordon P; Hampton J; Hawtin S; Ibanez M; Jiang T; Junt T; Knoepfel T; Liu B; Maginnis J; McKeever U; Michellys PY; Mutnick D; Nayak B; Niwa S; Richmond W; Rush JS; Syka P; Zhang Y; Zhu X
Bioorg Med Chem Lett; 2020 Sep; 30(17):127366. PubMed ID: 32738975
[TBL] [Abstract][Full Text] [Related]
8. TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation.
Bender AT; Tzvetkov E; Pereira A; Wu Y; Kasar S; Przetak MM; Vlach J; Niewold TB; Jensen MA; Okitsu SL
Immunohorizons; 2020 Feb; 4(2):93-107. PubMed ID: 32086319
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the role of nucleic acid antigens in murine models of systemic lupus erythematosus.
Watkins AA; Bonegio RG; Rifkin IR
Methods Mol Biol; 2014; 1169():143-58. PubMed ID: 24957237
[TBL] [Abstract][Full Text] [Related]
10. MiR-574-5p activates human TLR8 to promote autoimmune signaling and lupus.
Wang T; Song D; Li X; Luo Y; Yang D; Liu X; Kong X; Xing Y; Bi S; Zhang Y; Hu T; Zhang Y; Dai S; Shao Z; Chen D; Hou J; Ballestar E; Cai J; Zheng F; Yang JY
Cell Commun Signal; 2024 Apr; 22(1):220. PubMed ID: 38589923
[TBL] [Abstract][Full Text] [Related]
11. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9.
Wang J; Shao Y; Bennett TA; Shankar RA; Wightman PD; Reddy LG
J Biol Chem; 2006 Dec; 281(49):37427-34. PubMed ID: 17040905
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases.
Deshmukh A; Pereira A; Geraci N; Tzvetkov E; Przetak M; Catalina MD; Morand EF; Bender AT; Vaidyanathan B
J Pharmacol Exp Ther; 2024 Feb; 388(3):751-764. PubMed ID: 37673681
[TBL] [Abstract][Full Text] [Related]
13. Lupus Autoimmunity and Metabolic Parameters Are Exacerbated Upon High Fat Diet-Induced Obesity Due to TLR7 Signaling.
Hanna Kazazian N; Wang Y; Roussel-Queval A; Marcadet L; Chasson L; Laprie C; Desnues B; Charaix J; Irla M; Alexopoulou L
Front Immunol; 2019; 10():2015. PubMed ID: 31552019
[TBL] [Abstract][Full Text] [Related]
14. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
[TBL] [Abstract][Full Text] [Related]
15. TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages.
Odoardi N; Kourko O; Petes C; Basta S; Gee K
J Innate Immun; 2021; 13(6):345-358. PubMed ID: 34058746
[TBL] [Abstract][Full Text] [Related]
16. Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus.
Umiker BR; Andersson S; Fernandez L; Korgaokar P; Larbi A; Pilichowska M; Weinkauf CC; Wortis HH; Kearney JF; Imanishi-Kari T
Eur J Immunol; 2014 May; 44(5):1503-16. PubMed ID: 24500834
[TBL] [Abstract][Full Text] [Related]
17. TLR7 Protein Expression in Mild and Severe Lupus-Prone Models Is Regulated in a Leukocyte, Genetic, and IRAK4 Dependent Manner.
Celhar T; Lu HK; Benso L; Rakhilina L; Lee HY; Tripathi S; Zharkova O; Ong WY; Yasuga H; Au B; Marlier D; Lim LHK; Thamboo TP; Mudgett JS; Mackey MF; Zaller DM; Connolly JE; Fairhurst AM
Front Immunol; 2019; 10():1546. PubMed ID: 31354711
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9.
Kandimalla ER; Bhagat L; Wang D; Yu D; Sullivan T; La Monica N; Agrawal S
Nucleic Acids Res; 2013 Apr; 41(6):3947-61. PubMed ID: 23396449
[TBL] [Abstract][Full Text] [Related]
19. Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay.
Knoepfel T; Nimsgern P; Jacquier S; Bourrel M; Vangrevelinghe E; Glatthar R; Behnke D; Alper PB; Michellys PY; Deane J; Junt T; Zipfel G; Limonta S; Hawtin S; Andre C; Boulay T; Loetscher P; Faller M; Blank J; Feifel R; Betschart C
J Med Chem; 2020 Aug; 63(15):8276-8295. PubMed ID: 32786235
[TBL] [Abstract][Full Text] [Related]
20. Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs.
Hung YF; Chen CY; Shih YC; Liu HY; Huang CM; Hsueh YP
J Cell Biol; 2018 Aug; 217(8):2727-2742. PubMed ID: 29777026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
